Fate Therapeutics Inc. buy BiotechBee
Start price
26.10.22
/
70%
€20.67
Target price
31.12.24
€35.00
Performance (%)
-41.33%
End price
21.12.22
€12.12
Summary
This prediction ended on 21.12.22 with a price of €12.12. Massive losses of -41.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | 79.341% | 79.341% | 95.534% | -60.832% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% | 50.231% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% | 101.082% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% | 69.384% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% | 70.971% |
According to BiotechBee what are the pros and cons of Fate Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0